Clinical Trial Update: The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment [Phase 2]

View source ↗

Summary

This Phase 2 study is evaluating the efficacy and safety of induction therapy combining belimumab and telitacicept in proliferative lupus nephritis, compared wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• BENLYSTA (belimumab)
• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)
• Telitacicept

Snippet

Sponsor: Nanjing University School of Medicine | Conditions: Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN) | Phase 2 | Status: RECRUITING